![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » ACTAVIS ANNOUNCES FDA WARNING LETTER FOLLOWING FDA INSPECTION
ACTAVIS ANNOUNCES FDA WARNING LETTER FOLLOWING FDA INSPECTION
Actavis Group, the international generic pharmaceuticals company, announced that it has received a warning letter from the U.S. Food and Drug Administration (FDA), related to its inspection of the Group's solid oral dose manufacturing facility in Little Falls, New Jersey.
Web Wire (http://www.webwire.com/ViewPressRel.asp?aId=20270)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct